Previously, we reported that M-CSF induced monocyte survival through the activation of Akt, p38 MAPK and Erk1/2 kinases. Here, we found that Src family kinases were upstream of these kinases and played a central role in regulating M-CSF-induced monocyte survival. We observed that M-CSF promoted c-Src activation in monocytes and MDMs in a time-dependent manner. Src inhibitors reduced M-CSF-mediated phosphorylation of the M-CSF receptor (M-CSFR), Akt, Erk1/2, and p38 MAPK. We also observed that Src directly phosphorylated the M-CSFR. Notably, the inhibitors blocked phosphorylation of specific tyrosine residues within the M-CSFR. We further demonstrated that the Src inhibitor, PP2, attenuated M-CSF-induced NF-κB activation and M-CSF-induced monocyte survival. These findings indicated that Src family kinases mediate monocyte survival through the regulation of receptor phosphorylation and modulation of downstream signaling events. Thus, we predict that targeting Src family kinases may have therapeutic implication in inflammatory diseases.
INTRODUCTION
Monocytes are derived from bone marrow progenitor cells. Once released into circulation, a monocyte's lifespan is 24 -48 hours [1] . However, when a monocyte encounters specific growth factors, inflammatory cytokines or bacterial components, the monocyte enters the tissue and differentiates into a specialized tissue macrophage [2, 3] . Macrophage colony-stimulating factor (M-CSF) is important in promoting maturation of monocytes to macrophages as well as the survival of both cell types [4, 5] . Survival of monocytes and macrophages occurs through the activation of Akt, Erk, p38 and JNK [6] [7] [8] . Previously, we reported that M-CSF activates Akt by suppressing caspase-3 and caspase-9 activity [5] .
M-CSF mediates the proliferation of monocyte precursors and their differentiation into mature phagocytes through its interactions with the cell surface M-CSF receptor (M-CSFR) [3] . The M-CSFR is a disulfide-linked homodimer, encoded by c-Fms proto-oncogene [9] . The M-CSFR is a member of the receptor tyrosine kinase (RTK) family, which includes platelet-derived growth factor (PDGF) receptor, c-Kit and Flt3/Flt2 receptors [10] . The M-CSFR is comprised of an Ig-like extracellular domain, juxtamembrane domain, and important intracellular domains required for its catalytic activity including ATP binding domain, kinase insert domain, and major kinase domain [11] . Upon M-CSF stimulation, the human M-CSFR undergoes dimerization and autophosphorylation of specific five tyrosine residues (561, 699, 723, 809 and 823) as well as ubiquitination leading to its degradation and limitation of its intracellular signaling. Phosphorylated receptor tyrosine residues are docking sites for adaptor and signaling molecules, such as Src family kinases, PI3-kinase/Akt and Ras/MAPK leading to the induction of a cascade of signaling events resulting in cell differentiation, proliferation and survival (see reviews [12, 13] ).
Src protein tyrosine kinase (PTK) family members belong to the non-receptor tyrosine kinases and are implicated in multiple signaling pathways that regulate cellular growth, migration, differentiation and survival (see review [14] ). There are eight Src family kinases in vertebrates including Blk, Fyn, Fgr, Hck, Lck, Lyn, Src and Yes. Among these kinases, Hck, Lyn and Fgr are restricted to myeloid cells and B-lymphocytes, while c-Src, Yes and Fyn are ubiquitously expressed (see review [15] ). All Src family kinase members possess an N-terminal unique region, a Src homology 3 (SH3) domain which binds proline rich motifs, a Src homology 2 (SH2) domain, which interacts with phosphotyrosine motifs, and a kinase domain (see review [16] ). Src family kinases act in either a positive or a negative fashion. The Src family kinases interact with the human M-CSFR at Tyr  561 residue (mouse Tyr  559 ) and Tyr  809 residue (mouse Tyr   807 ) (see review [12] ). The Src family kinase member, c-Src, is one of the most studied member. Notably, this 60 KDa protein has two phosphorylation sites, which positively and negatively regulates its activity to ultimately regulate signal transduction pathways. Phosphorylation of Tyr 416 activates c-Src kinase activity, while Tyr 527 phosphorylation leads to inactivation of the kinase [17] .
We previously reported that M-CSF induces the activation of Erk1/2, Akt, and p38 MAPK to regulate monocyte survival [18, 19] . We therefore postulated that M-CSF induces these signaling molecules and perhaps proximally through Src family kinase activation. We observed that M-CSF induced c-Src activation in monocytes. We also found that c-Src induced M-CSFR phosphorylation. Furthermore, Src family kinase inhibition reduced M-CSF-induced receptor phosphorylation as well as downstream activation events, including Akt, Erk1/2, and p38 MAPK phosphorylation resulting in a decrease in cell survival and NF-κB activation. Thus, our data indicated that members of the Src family kinases serve as a critical regulatory factor in M-CSF-mediated monocyte survival.
MATERIALS AND METHODS

Reagents
Endotoxin-free RPMI-1640 and PBS were purchased from Mediatec (Herndon, VA) and endotoxin-free FBS was from Atlanta Biotec (Lawrenceville, GA). Recombinant human M-CSF was purchased from R&D Systems (Minneapolis, MN). The Src kinase inhibitor, pyrrolopyrimidine (PP2); the inactive analog, PP3 and the Src family inhibitor, SU6656 were obtained from EMD Chemicals (Gibbstown, NJ 
Cell Lines
Murine NIH-3T3 fibroblasts stably expressing the human M-CSFR (c-Fms) and designated 3T3/fms were maintained in DMEM supplemented with 10% FBS and 1% antibiotic-antimycotic (PSA: 1000 U/ml penicillin G sodium, 1000 µg/ml streptomycin sulfate, and 250 ng/ml amphotericin B) as described previously [20] . Prior to M-CSF stimulation, cells were serum starved in DMEM media on ice for 4 -6 hours [8, 20] .
Purification of Peripheral Blood Monocytes and the Generation of Monocyte-Derived Macrophages (MDMs)
Peripheral blood monocytes were isolated from buffy coats obtained from the American Red Cross and purified by positive selection using CD14 Monocyte Isolation Kit from Miltenyi Biotech (Auburn, CA) as described previously [19] . The purity of the monocyte preparation was confirmed by flow cytometry (LSRII; BD BioSciences, San Jose, CA). The CD14 + isolation resulted in 97% ± 3% purity. After isolation, monocytes were resuspended at 1 -10 × 10 6 cells/ml in RPMI-1640 medium supplemented with 10% FBS, 10 µg/ml polymyxin B and 20 ng/ml recombinant human M-CSF then cultured overnight. The next day, cells were washed and serum starved in RPMI-1640 medium for 2 hours. Prior to M-CSF (100 ng/ml) stimulation, the cells were treated with the Src inhibitors, SU6656 or PP2, or the control inactive analog, PP3 as indicated. Since monocytes cultured for 24 hours in M-CSF are not fully differentiated macrophages, we refer to these cells as monocytes throughout this paper.
To obtain monocyte-derived macrophages (MDMs), freshly isolated monocytes were incubated in RPMI-1640 medium containing 10% FBS, 10 µg/ml polymyxin B and 20 ng/ml M-CSF in a 37˚C CO 2 incubator for 5 -6 days. M-CSF was replenished and maintained in the culture by the addition of 20 ng/ml of M-CSF every other day. Differentiated MDMs were serum-starved overnight at 37˚C before being re-stimulated with M-CSF [19, 20] .
Prior to stimulation, monocytes were serum starved in RPMI-1640 medium at 37˚C incubator for two hours. MDMs were serum starved at 37˚C in a CO 2 incubator overnight. The next day, the media was replaced and the cells were serum starved for another two hours prior to stimulation.
Immunoprecipitation and Immunoblotting
Monocytes or MDMs were lysed on ice for 15 minutes in 1× lysis buffer (Cell Signaling Technology) containing protease inhibitor cocktail III (EMD Chemicals). Lysates were cleared of insoluble material then the protein concentration was determined by BioRad DC protein kit (BioRad, Hercules, CA). The samples were separated on 10% Bis-Tris SDS-PAGE gel with MOPS running buffer, transferred to a nitrocellulose membrane, probed with the indicated antibodies, and detected by ECL (Amersham Biosciences, Piscataway, NJ). The ECL signal was quantified using the Quantity One densitometry program (BioRad). Phosphorylation data was normalized to total protein controls or β-actin and expressed as fold-change from non-stimulated samples.
In Vitro Kinase Assay
After serum starvation, 3T3/fms cells were lysed in cell lysis buffer and equal amount of protein (0.8 -1 mg) was immunoprecipitated with irrelevant antibody control or M-CSFR antibody overnight at 4˚C. The immune complexes were then incubated with protein G beads (Life Technologies, Grand Island, NY) at 4˚C for 1 hour. The beads were washed three times in ice-cold lysis buffer, then twice in ice-cold kinase buffer containing 25 mM Tris-HCl (pH 7.5), 5 mM beta-glycerophosphate, 2 mM dithiothreitol (DTT), 0.1 mM Na 3 VO 4 and 10 mM MgCl 2 . The beads were pre-incubated in 20 μl kinase buffer with 10 μm of PP2, PP3 or SU6656 at 37˚C for 30 minutes prior to the addition of 100 μM ATP, 20 ng of recombinant active c-Src or both then incubated at 30˚C for an additional 30 minutes. The reactions were subjected to SDS-PAGE analysis on a 10% SDS polyacrylamide gel. After electrophoresis, proteins were transferred onto a nitrocellulose membrane, probed with phosphotyrosine antibodies, and reblotted with M-CSFR antibodies. M-CSFR phosphorylation was quantified by comparing band densitometry of phospho-M-CSFR and normalizing these values to the total M-CSFR signals in the respective lanes.
Caspase-3 Analysis
Caspase-3 activity assay was described previously [21] . Briefly, monocytes (5 × 10 6 cell/condition) were treated with inhibitors for 30 minutes prior to the addition of M-CSF (100 ng/ml) then incubated overnight at 37˚C. The next day, both the suspension and adherent cells were collected and caspase-3 activity was analyzed using the fluorogenic substrate Ac-DEVD-AMC (N-acetyl-(Asp-Glu-Val-Asp)-(7-amino-4-methylcoumarin)) (EMD Chemicals) as measured with Cytofluor 4000 fluorometer (Perseptive, Framingham, MA). The linear change of the fluorescence of hydrolyzed free AMC was used to calculate caspase-3 activity. Protein concentration was measured using BCA protein assay kit (Therma Scientific, Rockford, IL). Caspase-3 activity is presented as the relative fold-increase in the individual sample readout over M-CSF-stimulated sample readout per total protein and are expressed as the mean ± SEM.
Annexin V/PI Apoptosis Assay
Annexin V/PI cell apoptosis assay was performed as described previously [19] using the Annexin V-FITC apoptosis detection kit (BD PharMingen, San Diego, CA). Briefly, human monocytes (5 × 10 6 ) were incubated with inhibitors for 30 minutes in serum free X-vivo (Lonza Walkersville Inc., Walkersville, MD) before the addition of M-CSF (100 ng/ml) then incubated overnight at 37˚C. The cells were removed from the culture dish using Accutase (eBioscience, San Diego, CA), then stained with Annexin V-FITC and PI. The cells were analyzed by flow cytometry. Annexin V-FITC and PI double positive cells were considered apoptotic cells for the statistical analysis.
Transfection of Monocytes and NF-κB Activity Assay
Transient transfection of primary human monocytes was performed as described previously [19] using the Amaxa Nucleofector system (Lonza, Walkersville, MD). The NF-κB-luc secreted alkaline phosphatase (SEAP) reporter assay was performed as described previously [20] . Briefly, monocytes (15 × 10 6 ) isolated from buffy coats were resuspended in Monocyte Transfection Solution (Lonza) containing 2 µg of NF-κB-Luc construct and transfected using the Amaxa program Y-01. The cells were immediately washed in warm X-vivo medium and plated in triplicate in 24-well plates. After an hour, the monocytes were incubated with inhibitors for 30 minutes in X-vivo medium before addition of M-CSF (100 ng/ml) then cultured overnight at 37˚C. Luciferase production was measured with the Luciferase Assay System using a Luminometer (Promega, Madison, WI). Data are presented as the relative fold increase in luciferase production over nonstimulated mock transfected samples and are expressed as the mean ± SEM.
Statistical Analysis
All data are expressed as the mean ± SEM derived from at least three independent studies. Statistical analysis was performed with SPSS17 software (SPSS Inc. Chicago, IL) by using independent sample t-test. Statistical significance was defined as p < 0.05.
RESULTS
M-CSF Induced Src Activation in Human Monocytes and MDM
In this study, we hypothesized that Src family kinases are involved in M-CSF-regulated survival pathways in both monocytes and macrophages. Since Src family kinases are tyrosine phosphorylated following M-CSF stimulation in fibroblast cell lines overexpressing c-Fms [22] , we first examined whether M-CSF directly activated c-Src as proximal kinase, in primary human monocytes (Figures 1(a)-(d) ). Significant increase of c-Src phosphorylation was observed after 5 and 10 minutes of M-CSF stimulation in monocytes, while c-Src phosphorylation was significantly increased within 2 minutes of M-CSF stimulation in MDMs. The phosphorylation then returned to basal levels after 20 minutes of stimulation in both monocytes and MDMs.
family [24] , we were interested in determining whether the M-CSFR is also a substrate for Src family kinases. To test this hypothesis, we treated the cells with Src kinase inhibitors, PP2 or SU6656, or an inactive analogue, PP3, prior to M-CSF stimulation and then examined M-CSFR phosphorylation. Since M-CSFR is expressed at very low levels in monocytes and is up-regulated during macrophage differentiation [11] , we utilized MDMs to examine M-CSFR phosphorylation. As shown in Figures 2(a) and  (b) , tyrosine phosphorylation of the M-CSFR was enhanced in response to M-CSF, but was significantly reduced by the PP2 inhibitor, but not inactive analogue PP3. Similar reduction in receptor phosphorylation was observed in cells treated with M-CSF and the SU6656 inhibitor. Importantly, using trypan blue exclusion, we did not detect non-specific cytotoxicity from the inhibitors (data not shown). These data suggested that the -CSFR is a substrate for Src family kinases.
Src Kinase Inhibitors Reduced M-CSF-Induced M-CSFR Phosphorylation
Previous research reported that the PDGF receptor is a substrate for Src kinases [23] . Since both the M-CSFR and PDGFR are in the same tyrosine kinase receptor M Since global tyrosine phosphorylation of the M-CSFR was reduced in the presence of M-CSF and Src kinase inhibitors, we examined whether this inhibition affected a specific tyrosine residue. To analysis the phosphorylation status of specific tyrosine residues, we utilized the 3T3/fms cell line to ensure sufficient M-CSFR levels to be visualized by western blot analysis. The 3T3/fms cells were pretreated with either PP2 or SU6656 prior to stimulation with M-CSF then divided among separate gels for western blot analysis with each phospho-tyrosine antibody as indicated. Similar to MDMs, Src inhibition reduced M-CSF mediated phosphorylation in 3T3/fms cells (Figure 3(a) ). In the presence of M-CSF and either Src kinase inhibitors, PP2 or SU6656, as indicated, reduced M-CSFR tyrosine phosphorylation at residues 699, 723 and 809 was apparent with (Figure 3(a) ) while Tyr 561 was relatively unchanged. Notably, Tyr 561 of the M-CSFR is the Src docking site (see review [13] ).
The M-CSFR Is a Substrate for c-Src
To further confirm that the M-CSFR can be directly phosphorylated by Src kinases, we performed an in vitro kinase activity assay. To perform the kinase assay, the immunoprecipitated M-CSFR from 3T3/fms cells was incubated with or without recombinant active c-Src protein (Figures 3(b) and (c) ). Due to intrinsic kinase activity of the receptor, we detected M-CSFR phosphorylation in the presence of ATP alone (Figure 3(c) , ATP) or ATP and the inactive analog PP3 (Figure 3(b) , PP3 + ATP). In samples treated with both recombinant active c-Src and ATP (PP3 + Src + ATP or Src + ATP), we observed increased M-CSFR phosphorylation compared to samples treated with ATP only (ATP or PP3 + ATP) (Figures  3(b) and (c) ). Interestingly, there was a 54% ± 6% and 42% ± 18% decrease in M-CSFR phosphorylation in the presence ATP alone with either PP2 or SU6656, respectively. This observation reflects the ability of the inhibitors to non-selectively interfere with intrinsic kinase activity of the M-CSFR. Using Src kinase inhibitors in the presence of ATP and recombinant active c-Src, we observed further reduction in M-CSFR phosphorylation compared to the control samples. Notably, there was a 75% ± 3% reduction in receptor phosphorylation comparing PP2 + c-Src + ATP samples to PP3 + c-Src + ATP samples (Figure 3(b) ). Likewise, there was an 82% ± 8% reduction in M-CSFR phosphorylation in SU6656 + c-Src + ATP samples compared to c-Src + ATP samples (Figure 3(c) ). As expected, treatment with the inhibitors with or without recombinant active c-Src in the absence of ATP did not induce M-CSFR phosphorylation. Thus, our data indicated that the M-CSFR is a substrate for Src family kinases.
Therefore, we next examined the role of Src family kinases in M-CSFR-mediated activation of these signaling molecules in monocytes and MDMs. Since these cells contain multiple Src kinase members, we used the general Src tyrosine kinase inhibitor, PP2 instead of trying to use multiple siRNAs. Monocytes and MDMs were treated with either PP2 or the control, PP3, for 30 minutes prior to M-CSF stimulation and then phosphorylation of the signaling molecules was examined. As predicted, PP2, but not the inactive analogue PP3, significantly reduced M-CSF-induced phosphorylation of Akt, Erk1/2 and p38 in human monocytes (Figures 4(a) and  (b) ) and MDMs (Figures 4(c) and (d) ).
Inhibition of Src Kinases Reduce M-CSF-Induced NF-κB Activity in Human Monocyte
Since NF-κB activity is important in monocyte survival and function [19, 20] , we next examined the role of Src family kinases on M-CSF-induced NF-κB activation in monocytes. To examine NF-κB activity, we utilized a luciferase reporter system. Monocytes transiently transfected with a NF-κB-Luc construct were cultured in the absence or presence of Src kinase inhibitors with M-CSF. Following, M-CSF stimulation, NF-κB-transcriptional activity was increased in monocytes ( Figure 5) . Notably, the kinase inhibitor PP2 reduced M-CSF-induced NF-κB activity (p < 0.05).
Activation of Src Kinases Is Important in M-CSF Mediated Survival in Monocytes
Previously, our laboratory reported that the activation of Akt, Erk1/2 and NF-κB is important in monocyte survival [5, 7] . Since inhibition of Src family kinases prevented M-CSF-induced receptor phosphorylation as well as downstream activation of signaling path ways in Figure 4 . Inhibition of Src kinases suppresses M-CSF-induced Akt, Erk1/2 and p38 phosphorylation in primary human monocytes and MDMs. Freshly isolated monocytes (a) or MDMs (c) were incubated with DMSO solvent, PP2 or PP3 (10 μM) for 30 minutes before stimulation with M-CSF at 37˚C for 5 minutes. Cells were lysed and equal amount of protein was resolved using a 10% SDS-PAGE gel then immunoblotted with the indicated antibodies. Equal loading was confirmed by reblotting the membranes with β-actin antibody. Phosphorylation levels were quantified by comparing the densitometry of the phosphorylated protein bands to β-actin. The data are presented as the mean ± SEM from three independent donors ( * p < 0.05). were transfected with 2 µg of NF-κB-Luc construct or eGFP control construct. After an hour, the monocytes were incubated with inhibitors for 30 minutes in X-vivo medium before addition of M-CSF (100 ng/ml) then cultured overnight at 37˚C. Cells were lysed and luciferase activity was measured using a luminometer to detect luciferase activity. Data are presented as the relative fold-increase in non-stimulated mock transfected samples and are expressed as the mean ± SEM from three independent donors done in triplicate ( * p < 0.05 compared with DMSO alone treated samples).
monocytes, we next examined if cell survival was altered by Src family kinase inhibition. As shown in Figure 6(a) , non-stimulated cells (DMSO) had high levels of caspase-3 activity compared to M-CSF-treated cells (DMSO + M-CSF) (p < 0.05). As expected, the Src family kinase inhibitor PP2, but not the inactive analogue PP3, induced caspase-3 activity in M-CSF-stimulated monocytes.
As an alternative method of measuring cell apoptosis, we measured Annexin V/PI staining in the treated cells by flow cytometry. Apoptotic cells were designated as Annexin V+/PI− (early apoptosis) and Annexin V+/PI+ populations (late apoptosis) while viable cells were Annexin V−/PI−. Compared to DMSO treated cells, M-CSF protected monocytes from apoptosis, but inhibition of Src family kinases with PP2 in the presence of M-CSF significantly reduced the survival of the monocytes (Figure 6(b) ). Collectively, these data showed that Src family kinases regulate M-CSF-induced survival of human monocyte survival through NF-κB activation as well as other pathways in monocytes.
DISCUSSION
Previously, we found M-CSF modulates monocyte survival by activating Akt, p38 MAPK, and Erk1/2 kinases [5, 18, 19] . In this study, we focused on understanding the role of Src family kinases as proximal signaling intermediaries in downstream networks activated by M-CSF in monocytes and MDMs. We found cross-talk between Src family kinases and the M-CSFR. Specifically, inhibition of Src family kinase activity in monocytes and MDMs reduced the activation of Akt, Erk1/2 and p38 MAPK and induced monocyte apoptosis. Moreover, inhibition of Src family kinases decreased NF-κB transcriptional activity after M-CSF stimulation. Our data indicate that Src family kinases play central roles in the M-CSF-mediated primary myeloid cell survival.
The well-established paradigm is M-CSF binds the M-CSFR, leading to receptor dimerization and autophosphorylation, providing docking sites for signaling molecules. Src family kinases bind the phosphorylated Tyr 561 residue in human M-CSFR (or Tyr 559 in the murine M-CSFR) resulting in their activation and downstream signaling events [12] . Since there are nine Src family kinase members in myeloid cells and their function are redundant, it is not feasible to use molecular and genetic approaches to reduce these kinases. Targeting c-Src alone with siRNA or a dominant negative construct was not effective in our hands. Thus, requiring the use of the pharmacological Src family kinase inhibitors PP2 or SU6656 to effective inhibits the activity of all Src family kinase members.
Since, we observed that M-CSFR phosphorylation was reduced by inhibition of Src kinases this suggested that Src family kinases also mediate M-CSFR phosphorylation, similar to the finding that the PDGF receptor is a substrate for Src kinases [25] . Interestingly, the mutant Y559F murine M-CSFR reduces M-CSFR phosphorylation [26] , while mutations at tyrosine residues 706, 921 or 947 do not affect receptor tyrosine phosphorylation [3] . In the presence of Src inhibitors, phosphorylation of the Tyr 561 of the human M-CSFR was relatively unchanged but reduced at other residues. The in vitro kinase activity assay using human M-CSFR further demonstrated that the receptor could serve as a substrate for c-Src. Similar to our findings, Galvagni and colleagues recently reported the Src-dependent phosphorylation of VEGFR-3 in endothelial cells [27] . Furthermore, PP2 reduced EGFinduced VEGFR-3 receptor phosphorylation [27] . Interestingly, ROS can activate Src kinases independent of receptor activation [28] . In turn, ROS-activated Src kinases mediate PDGF receptor phosphorylation [28] . We also observed that ROS mediate M-CSFR phosphorylation through a Src-dependent pathway (data not shown). Since, the M-CSFR belongs to the same RTK family as VEGF and PDGF receptors, it is likely this phosphorylation feedback loop is conserved among RTKs.
The role of Src family kinase activation in regulating monocyte survival and proliferation has been reported. In microglia, GM-CSF activates the Src family kinase, Hck, which is involved in the activation of PI-3K/Akt cell proliferation and survival [29] . Our laboratory reported that Lyn, another Src family kinase, negatively regulates M-CSF-induced monocyte survival by recruiting SHIP1 to the cell membrane and down regulating PI-3K/Akt activation [30] . Moreover, Lyn −/− macrophages have increased Akt activity in response to M-CSF [30] . Consistent with these observations, we found that Src family kinases are important in M-CSF-induced activation of PI-3K/Akt and Erk pathways [10] . Most recently, Rovida and colleagues reported Src kinase inhibitors reduced M-CSF-induced Akt and Erk5 phosphorylation in human and mouse macrophage cell lines [31] . In our study, we found that pharmacological inhibition of Src family kinases reduced tyrosine phosphorylation of the M-CSFR at tyrosine residues 699, 723 and 809 that provide docking sites for intracellular signaling proteins such as Grb2-SOS, PI3-Kinase and Ras that regulate cellular survival pathways in monocytes (see review [13] ). Taken together, these observations indicate that Src kinases are pivotal in regulating M-CSF signaling as well as survival pathways.
In summary, this study demonstrates that Src family kinases play a central role in primary mononuclear phagocytes survival by contributing to M-CSFR activation and downstream signaling events. In conditions such as chronic inflammation where there is prolonged survival of macrophages, it is possible that targeting Src kinases to limit cell survival and tissue damage may be a beneficial therapeutic option. Current studies are underway to examine the activation of Src kinases in chronic inflammatory diseases.
